Log in to save to my catalogue

Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocri...

Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocri...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_514809

Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases

About this item

Full title

Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Neuroendocrinology, 2022-02, Vol.112 (2), p.143-152

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Introduction: The combined use of 68 gallium ( 68 Ga)-DOTA-peptides and 18 fluorine-fluoro-2-deoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) scans in the workup of pancreatic neuroendocrine tumors (PanNETs) is controversial. This study aimed at assessing both tracers’ capability to identify tumors and to assess it...

Alternative Titles

Full title

Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_karger_primary_514809

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_514809

Other Identifiers

ISSN

0028-3835

E-ISSN

1423-0194

DOI

10.1159/000514809

How to access this item